Task: Answer the multiple choice question.
Question: Which drug exhibits a -13.996% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) CCOC(=O)/C(C#N)=C\c1ccc(CC)s1
b) CCOC(=O)C1=C(N)Oc2cc(O)ccc2C1c1cccc([N+](=O)[O-])c1
c) CC1CCN(CCC(=O)N2CCCc3c2c(=O)oc2ccc(O)cc32)CC1
d) Cc1ccsc1C(C(=O)NC1CCCCC1)N(C(=O)c1csnn1)C1CC1
e) CCOc1ccccc1C(C(=O)NC1CCCC1)N(Cc1ccco1)C(=O)CNC(=O)c1ccco1
Answer: c. CC1CCN(CCC(=O)N2CCCc3c2c(=O)oc2ccc(O)cc32)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(CCC(=O)N2CCCc3c2c(=O)oc2ccc(O)cc32)CC1
CC1CCN(CCC(=O)N2CCCc3c2c(=O)oc2ccc(O)cc32)CC1
9-hydroxy-4-[3-(4-methylpiperidin-1-yl)propanoyl]-2,3-dihydro-1H-chromeno[3,4-b]pyridin-5-one